Literature DB >> 24510338

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.

Birgitta Sander1, Daphne de Jong, Andreas Rosenwald, Wanling Xie, Olga Balagué, Maria Calaminici, Joaquim Carreras, Philippe Gaulard, John Gribben, Anton Hagenbeek, Marie José Kersten, Thierry Jo Molina, Abigail Lee, Santiago Montes-Moreno, German Ott, John Raemaekers, Gilles Salles, Laurie Sehn, Christoph Thorns, Björn E Wahlin, Randy D Gascoyne, Edie Weller.   

Abstract

The cellular microenvironment in follicular lymphoma is of biological and clinical importance. Studies on the clinical significance of non-malignant cell populations have generated conflicting results, which may partly be influenced by poor reproducibility in immunohistochemical marker quantification. In this study, the reproducibility of manual scoring and automated microscopy based on a tissue microarray of 25 follicular lymphomas as compared to flow cytometry is evaluated. The agreement between manual scoring and flow cytometry was moderate for CD3, low for CD4, and moderate to high for CD8, with some laboratories scoring closer to the flow cytometry results. Agreement in manual quantification across the 7 laboratories was low to moderate for CD3, CD4, CD8 and FOXP3 frequencies, moderate for CD21, low for MIB1 and CD68, and high for CD10. Manual scoring of the architectural distribution resulted in moderate agreement for CD3, CD4 and CD8, and low agreement for FOXP3 and CD68. Comparing manual scoring to automated microscopy demonstrated that manual scoring increased the variability in the low and high frequency interval with some laboratories showing a better agreement with automated scores. Manual scoring reliably identified rare architectural patterns of T-cell infiltrates. Automated microscopy analyses for T-cell markers by two different instruments were highly reproducible and provided acceptable agreement with flow cytometry. These validation results provide explanations for the heterogeneous findings on the prognostic value of the microenvironment in follicular lymphoma. We recommend a more objective measurement, such as computer-assisted scoring, in future studies of the prognostic impact of microenvironment in follicular lymphoma patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510338      PMCID: PMC3971082          DOI: 10.3324/haematol.2013.095257

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  44 in total

1.  Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

Authors:  Annuska M Glas; Laurent Knoops; Leonie Delahaye; Marie José Kersten; Robby E Kibbelaar; Lodewyk A Wessels; Ryan van Laar; J Han J M van Krieken; Joke W Baars; John Raemaekers; Philip M Kluin; Laura J van't Veer; Daphne de Jong
Journal:  J Clin Oncol       Date:  2007-01-02       Impact factor: 44.544

2.  CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.

Authors:  Björn Engelbrekt Wahlin; Birgitta Sander; Birger Christensson; Eva Kimby
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

Review 3.  Prognostic factors in follicular lymphoma.

Authors:  Thomas Relander; Nathalie A Johnson; Pedro Farinha; Joseph M Connors; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

4.  The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.

Authors:  Tomás Alvaro; Marylène Lejeune; Francisca I Camacho; Ma Teresa Salvadó; Lydia Sánchez; Juan F García; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons; Carmen Bellas; Miguel A Piris
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

5.  High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

Authors:  Joaquim Carreras; Armando Lopez-Guillermo; Bridget C Fox; Lluis Colomo; Antonio Martinez; Giovanna Roncador; Emili Montserrat; Elias Campo; Alison H Banham
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

6.  Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment.

Authors:  Andrew J Clear; Abigail M Lee; Maria Calaminici; Alan G Ramsay; Kelly J Morris; Simon Hallam; Gavin Kelly; Finlay Macdougall; T Andrew Lister; John G Gribben
Journal:  Blood       Date:  2010-04-07       Impact factor: 22.113

7.  Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.

Authors:  Tomás Alvaro; Marylène Lejeune; Maria-Teresa Salvadó; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

8.  Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Daphne de Jong; Andreas Rosenwald; Mukesh Chhanabhai; Philippe Gaulard; Wolfram Klapper; Abigail Lee; Birgitta Sander; Christoph Thorns; Elias Campo; Thierry Molina; Andrew Norton; Anton Hagenbeek; Sandra Horning; Andrew Lister; John Raemaekers; Randy D Gascoyne; Gilles Salles; Edie Weller
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

9.  Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.

Authors:  Wolfram Klapper; Eva Hoster; Lars Rölver; Carsten Schrader; Dirk Janssen; Markus Tiemann; Heinz-Wolfram Bernd; Olaf Determann; Martin-Leo Hansmann; Peter Möller; Alfred Feller; Harald Stein; Hans-Heinrich Wacker; Martin Dreyling; Michael Unterhalt; Wolfgang Hiddemann; German Ott
Journal:  J Clin Oncol       Date:  2007-08-01       Impact factor: 44.544

10.  A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

Authors:  Minna Taskinen; Marja-Liisa Karjalainen-Lindsberg; Heidi Nyman; Leena-Maija Eerola; Sirpa Leppä
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531

View more
  13 in total

1.  Assessing the prognostic impact of immune cell infiltrates in follicular lymphoma.

Authors:  Falko Fend; Leticia Quintanilla-Martínez
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

2.  Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP.

Authors:  Rita Coutinho; Andrew J Clear; Emanuele Mazzola; Andrew Owen; Paul Greaves; Andrew Wilson; Janet Matthews; Abigail Lee; Rute Alvarez; Maria Gomes da Silva; José Cabeçadas; Donna Neuberg; Maria Calaminici; John G Gribben
Journal:  Haematologica       Date:  2014-11-25       Impact factor: 9.941

3.  Comparison of evaluation techniques, including digital image analysis, for MYC protein expression by immunohistochemical stain in aggressive B-cell lymphomas.

Authors:  Meghan Hupp; Sarah Williams; Brian Dunnette; Katelyn M Tessier; Elizabeth L Courville
Journal:  Hum Pathol       Date:  2018-08-30       Impact factor: 3.466

Review 4.  Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?

Authors:  Fabienne McClanahan; Thomas G Sharp; John G Gribben
Journal:  Haematologica       Date:  2016-10       Impact factor: 9.941

Review 5.  The tumour microenvironment in B cell lymphomas.

Authors:  David W Scott; Randy D Gascoyne
Journal:  Nat Rev Cancer       Date:  2014-07-10       Impact factor: 60.716

6.  The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.

Authors:  Harald Holte; Klaus Beiske; Merrill Boyle; Gunhild Trøen; Yngvild N Blaker; June Myklebust; Sunniva Kvaløy; Andreas Rosenwald; Ole C Lingjaerde; Lisa M Rimsza; Erlend B Smeland; David W Scott; Arne Kolstad
Journal:  Br J Haematol       Date:  2018-08-06       Impact factor: 6.998

7.  The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Authors:  Andreas Engert; Carlo Balduini; Anneke Brand; Bertrand Coiffier; Catherine Cordonnier; Hartmut Döhner; Thom Duyvené de Wit; Sabine Eichinger; Willem Fibbe; Tony Green; Fleur de Haas; Achille Iolascon; Thierry Jaffredo; Francesco Rodeghiero; Gilles Salles; Jan Jacob Schuringa
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

8.  Flow cytometric sorting coupled with exon capture sequencing identifies somatic mutations in archival lymphoma tissues.

Authors:  Nenggang Jiang; Christopher Chen; Qiang Gong; Kristen Shields; Yuping Li; YuanYuan Chen; Joo Song; Timothy W McKeithan; Wing C Chan
Journal:  Lab Invest       Date:  2017-08-07       Impact factor: 5.662

9.  A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

Authors:  Sarah Huet; Bruno Tesson; Jean-Philippe Jais; Andrew L Feldman; Laura Magnano; Emilie Thomas; Alexandra Traverse-Glehen; Benoit Albaud; Marjorie Carrère; Luc Xerri; Stephen M Ansell; Lucile Baseggio; Cécile Reyes; Karin Tarte; Sandrine Boyault; Corinne Haioun; Brian K Link; Pierre Feugier; Armando Lopez-Guillermo; Hervé Tilly; Pauline Brice; Sandrine Hayette; Fabrice Jardin; Fritz Offner; Pierre Sujobert; David Gentien; Alain Viari; Elias Campo; James R Cerhan; Gilles Salles
Journal:  Lancet Oncol       Date:  2018-02-20       Impact factor: 41.316

Review 10.  Microenvironment Cell Contribution to Lymphoma Immunity.

Authors:  Deepika Kumar; Mina L Xu
Journal:  Front Oncol       Date:  2018-07-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.